Role of p38 MAP kinase pathway in a toxin-induced model of hemolytic uremic syndrome

Pediatric Nephrology

Volumn 19, Issue 8, 2004, Pages 844-852

  Fu, Xue Jun ^a   Iijima, Kazumoto ^b   Nozu, Kandai ^a   Hamahira, Kiyoshi ^a   Tanaka, Ryojiro ^a   Oda, Tatsuya ^c   Yoshikawa, Norishige ^d   Matsuo, Masafumi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

^d WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

FR167653; Hemolytic uremic syndrome; Proinflammatory cytokines; Rat model; Ricin

Indexed keywords

1 [7 (4 FLUOROPHENYL) 1,2,3,4 TETRAHYDRO 8 (4 PYRIDYL)PYRAZOLO[5,1 C][1,2,4]TRIAZIN 2 YL] 2 PHENYLETHANEDIONE; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; RICIN; TOXIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; GLOMERULUS; HEMOLYSIS; HEMOLYTIC UREMIC SYNDROME; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; WESTERN BLOTTING;

EID: 4344659862     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-004-1502-4     Document Type: Article

References (41)

1. Koster F, Levin J, Walker L, Tung KSK, Gilman RH, Rahaman MM, Majid MA, Islam S, Williams RC (1978) Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N Engl J Med 298:927-933
2. Bitzan M, Moebius E, Ludwig K, Müller-Wiefel DE, Heesemann J, Karch H (1991) High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome. J Pediatr 119:380-385
3. Siegler RL (1995) The hemolytic uremic syndrome. Pediatr Clin North Am 42:1505-1529
4. Lopez EL, Contrini MM, Devoto S, De Rosa MF, Grana MG, Genero MH, Canepa C, Gomez HF, Cleary TG (1995) Tumor necrosis factor concentrations in hemolytic uremic syndrome patients and children with bloody diarrhea in Argentina. Pediatr Infect Dis J 14:594-598
5. Taylor CM, Williams JM, Lote CJ, Howie AJ, Thewles A, Wood JA, Milford DV, Raafat F, Chant I, Rose PE (1999) A laboratory model of toxin-induced haemolytic uraemic syndrome. Kidney Int 55:1367-1374
6. Licastro F, Morini MC, Bolognesi A, Stirpe F (1993) Ricin induces the production of tumour necrosis factor-alpha and interleukin-1 beta by human peripheral-blood mononuclear cells. Biochem J 294:517-520
7. Taylor FB Jr, Tesh VL, DeBault L, Li A, Chang AC, Kosanke SD, Pysher TJ, Siegler RL (1999) Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1. Am J Pathol 154:1285-1299
8. Hughes AK, Stricklett PK, Kohan DE (1998) Shiga toxin-1 regulation of cytokine production by human proximal tubule cells. Kidney Int 54:1093-1106
9. Hughes AK, Stricklett PK, Kohan DE (2001) Shiga toxin-1 regulation of cytokine production by human glomerular epithelial cells. Nephron 88:14-23
10. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270:7420-7426
11. Lee JC, Badger AM, Griswold DE, Dunnington D, Truneh A, Votta B, White JR, Young PR, Bender PE (1993) Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors. Ann N Y Acad Sci 696:149-170
12. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC (1995) SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364:229-233
13. Karnitz LM, Abraham RT (1995) Cytokine receptor signaling mechanisms. Curr Opin Immunol 7:320-326
14. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746
15. Badger AM, Bradbeer JN, Votta B, Lee JC, Adams JL, Griswold DE (1996) Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther 279:1453-1461
16. Jackson JR, Bolognese B, Hillegass L, Kassis S, Adams J, Griswold DE, Winkler JD (1998) Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models. J Pharmacol Exp Ther 284:687-692
17. Takahashi S, Shigeta J, Inoue H, Tanabe T, Okabe S (1998) Localization of cyclooxygenase-2 and regulation of its mRNA expression in gastric ulcers in rats. Am J Physiol 275:G1137-G1145
18. Kawano T, Ogushi F, Tani K, Endo T, Ohmoto Y, Hayashi Y, Sone S (1999) Comparison of suppressive effects of a new anti-inflammatory compound, FR167653, on production of PGE2 and inflammatory cytokines, human monocytes, and alveolar macrophages in response to endotoxin. J Leukoc Biol 65:80-86
19. Wadsworth SA, Cavender DE, Beers SA, Lalan P, Schafer PH, Malloy EA, Wu W, Fahmy B, Olini GC, Davis JE, Pellegrino-Gensey JL, Wachter MP, Siekierka JJ (1999) RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase. J Pharmacol Exp Ther 291:680-687
20. Takahashi S, Keto Y, Fujita T, Uchiyama T, Yamamoto A (2001) FR167653, a p38 mitogen-activated protein kinase inhibitor, prevents Helicobacter pylori-induced gastritis in Mongolian gerbils. J Pharmacol Exp Ther 296:48-56
21. Wada T, Furuichi K, Sakai N, Hisada Y, Kobayashi K, Mukaida N, Tomosugi N, Matsushima K, Yokoyama H (2001) Involvement of p38 mitogen-activated protein kinase followed by chemokine expression in crescentic glomerulonephritis. Am J Kidney Dis 38:1169-1177
22. Naruse I, Keino H, Kawarada Y (1994) Antibody against single-stranded DNA detects both programmed cell death and drug-induced apoptosis. Histochemistry 101:73-78
23. Frankfurt OS, Robb JA, Sugarbaker EV, Villa L (1996) Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis. Exp Cell Res 226:387-397
24. Watanabe I, Toyoda M, Okuda J, Tenjo T, Tanaka K, Yamamoto T, Kawasaki H, Sugiyama T, Kawarada Y, Tanigawa N (1999) Detection of apoptotic cells in human colorectal cancer by two different in situ methods: antibody against single-stranded DNA and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling (TUNEL) methods. Jpn J Cancer Res 90:188-193
25. Ostendorf T, Kunter U, Eitner F, Loos A, Regele H, Kerjaschki D, Henninger DD, Janjic N, Floege J (1999) VEGF165 mediates glomerular endothelial repair. J Clin Invest 104:913-923
26. Dawson-Saunders B, Trapp RG (1999) Comparing three or more means. In: Basic and clinical biostatistics, Appleton and Lange, Norwalk, pp 124-141
27. Tesh VL, Samuel JE, Perera LP, Sharefkin JB, O'Brien-AD (1991) Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J Infect Dis 164:344-352
28. Louise CB, Obrig TG (1992) Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect Immun 60:1536-1543
29. Barrett TJ, Potter ME, Wachsmuth IK (1989) Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice. Infect Immun 57:3434-3437
30. Richardson SE, Karmali MA, Becker LE, Smith CR (1988) The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol 19:1102-1108
31. Inward CD, Williams J, Chant I, Crocker J, Milford DV, Rose PE, Taylor CM (1995) Verocytotoxin-1 induces apoptosis in vero cells. J Infect 30:213-218
32. Mangeney M, Lingwood CA, Taga S, Caillou B, Tursz T, Wiels J (1993) Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen. Cancer Res 53:5314-5319
33. Sandvig K, Deurs B van (1992) Toxin-induced cell lysis: protection by 3-methyladenine and cycloheximide. Exp Cell Res 200:253-262
34. Taguchi T, Uchida H, Kiyokawa N, Mori T, Sato N, Horie H, Takeda T, Fujimoto J (1998) Verotoxins induce apoptosis in human renal tubular epithelium derived cells. Kidney Int 53: 1681-1688
35. Pijpers AH, Setten PA van, Heuvel LP van den, Assmann KJ, Dijkman HB, Pennings AH, Monnens LA, Hinsbergh VW van (2001) Verocytotoxin-induced apoptosis of human microvascular endothelial cells. J Am Soc Nephrol 12:767-778
36. Karpman D, Hakansson A, Perez MT, Isaksson C, Carleman E, Caprioli A, Svanborg C (1998) Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies. Infect Immun 66:636-644
37. Oda T, Komatsu N, Muramatsu T (1997) Cell lysis induced by ricin D and ricin E in various cell lines. Biosci Biotechnol Biochem 61:291-297
38. Baluna R, Coleman E, Jones C, Ghetie V, Vitetta ES (2000) The effect of a monoclonal antibody coupled to ricin A chain-derived peptides on endothelial cells in vitro: insights into toxin-mediated vascular damage. Exp Cell Res 258:417-424
39. Inward CD, Howie AJ, Fitzpatrick MM, Raffat F, Milford DV, Taylor MC (1997) Renal histopathology in fatal cases of diarrhoea-associated haemolytic uraemic syndrome. Pediatr Nephrol 11:556-559
40. Bohle A, Grabensee B, Fisher R, Berg E, Klust H (1985) On four cases of hemolytic-uremic syndrome without microangiopathy. Clin Nephrol 24:88-92
41. Kaplan BS, Proesmans W (1987) The hemolytic uremic syndrome of childhood and its variants. Semin Hematol 24:148-160